Clinical Trials
3 trialsNCT02711137 2025-10-21
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Phase 1/2 Terminated
NCT01193517 2020-04-15
Azacitidine and CAPOX in Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT02260440 2019-09-17
A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer
University of Pittsburgh
Phase 2 Completed